| GlaxoSmithKline AG - Zovirax, Suspension | | 47431 | | 01 | | Zovirax | | Suspension | | J05AB01 | | Aciclovir | | 13.07.1993 | | |
| | Composition | | aciclovirum 400 mg, sorbitolum liquidum non cristallisabile 2.25 g, glycerolum, cellulosum microcristallinum, carmellosum natricum conexum, aromatica Orangenaroma cum alcohol benzylicus, propylis parahydroxybenzoas 1 mg, E 218 5 mg, aqua purificata, ad solutionem pro 5 ml corresp. natrium 0.72 mg. | | Packungsbestandteile | | Suspension | | | | | | | | Principe actif | Concentr. |
|---|
| Aciclovir | 400mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Aciclovir | 400 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Aqua Purificata | | | | Aromatica Orangenaroma cum Alcohol Benzylicus | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 218 | 5mg / 5ml | conserv. | | Glycerol | | | | Propylis Parahydroxybenzoas | 1mg / 5ml | | | Sorbitolum Liquidum non Cristallisabile | 2.25g / 5ml | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 100 ml | 26.18 | 44.90 | A | LS | Oui |
|
|
